Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4915882_AE15882_0